Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Sigyn Therapeutics (SIGY) Stock Price & Analysis

SIGY Stock Chart & Stats

$0.03$0.00(0.00%)
At close: 4:00 PM EST
$0.025$0.03$0.0353 Aug17 Aug31 Aug15 Sep1 Oct12 Oct23 Oct
Day’s Range
$0.03 - $0.03
52-Week Range
$0.01 - $2.00
Previous Close
$0.03
Volume
N/A
Average Volume (3M)
4,587
Market Cap
$147.84K
Enterprise Value
$2.79T
Total Cash (Recent Filing)
$265
Total Debt (Recent Filing)
$3.18M
Price to Earnings (P/E)
―
Beta
0.41
Next Earnings
N/A
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Innovative Technology

The company's proprietary blood purification technology addresses critical medical needs, offering potential for strong market demand and strategic partnerships in healthcare.

Strategic Partnerships

Engaging in strategic partnerships can enhance technology distribution and application, driving long-term growth and market penetration in the healthcare sector.

Research Funding Opportunities

Access to research funding and government contracts can accelerate development and deployment of medical solutions, supporting innovation and financial sustainability.

Bears Say

Financial Instability

Persistent financial difficulties indicate challenges in achieving profitability and sustainability, posing risks to long-term operational viability and investor confidence.

Negative Cash Flow

Negative cash flow from operations suggests poor efficiency and high cash burn, necessitating reliance on external funding and impacting financial health.

Lack Of Revenue Growth

The absence of revenue growth highlights challenges in market competitiveness and operational performance, limiting the company's ability to scale and generate profits.

Sigyn Therapeutics News

SIGY FAQ

What was Sigyn Therapeutics’s price range in the past 12 months?
Sigyn Therapeutics lowest stock price was $0.01 and its highest was $2.00 in the past 12 months.
What is Sigyn Therapeutics’s market cap?
Sigyn Therapeutics’s market cap is $147.84K.
When is Sigyn Therapeutics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Sigyn Therapeutics’s earnings last quarter?
Sigyn Therapeutics released its earnings results on Nov 14, 2023. The company reported -$0.819 earnings per share for the quarter.
Is Sigyn Therapeutics overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Sigyn Therapeutics pay dividends?
Sigyn Therapeutics does not currently pay dividends.
What is Sigyn Therapeutics’s EPS estimate?
Sigyn Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sigyn Therapeutics have?
Sigyn Therapeutics has 5,318,034 shares outstanding.
What happened to Sigyn Therapeutics’s price movement after its last earnings report?
Sigyn Therapeutics reported an EPS of -$0.819 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Sigyn Therapeutics?
Currently, no hedge funds are holding shares in SIGY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology